In the U.K., two instances of evidently inept work by radiologists are inadvertently spotlighting the value of subspecialized image interpretation in socially sensitive patient cases.

A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.

Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, and chair of the ACR Breast Commission, discusses post-COVID-19 economic issues facing breast imaging centers, including staffing problems from the "Great Resignation" and lower reimbursements. 

Why are patients paying far less out of their pockets for mammography now than two decades ago—while shelling out a lot more for other common imaging exams?

Dense breast experts Wendie Berg, MD, and JoAnn Pushkin, executive director of DenseBreast-info Inc., explain the current status of breast density patient inform laws, reimbursement and new technologies to aid cancer detection. 

An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.

If generalizable AI models are to meaningfully contribute to precision cancer care, they’ll need to incorporate not only imaging data but also digitalized clinical notes, biomarker assays and monitor readouts.

These new findings could help providers differentiate and manage CP associated with different levels of motor impairment, authors of the study indicated.

The healthcare industry has faced numerous workforce challenges, including higher costs and turnover rates. Fortunately, the sector appears to be recovering from losses caused by the COVID-19 pandemic.